{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T11:10:54Z","timestamp":1794481854914,"version":"4.9.1"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"vor","delay-in-days":14,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Joint Funds for the innovation of science and Technology, Fujian province","award":["2021Y9072"],"award-info":[{"award-number":["2021Y9072"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To assess the prevalence of heteroresistance in 201 clinical isolates of Klebsiella pneumoniae to 16 clinically significant antibiotics. Furthermore, to investigate the interaction effects of combination antibiotic therapies for heteroresistant isolates.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Isolates were pre-screened for growth of resistant subpopulations at resistant breakpoint concentrations for each isolate\/antibiotic combination. Any strain containing colony growth at the resistant breakpoint was selected as a candidate heteroresistant strain, and population analysis profiling (PAP) tested for confirmation of HR phenotype. Dual PAP and time\u2013kill assay were conducted to assess the efficacy of antibiotic combinations in suppressing resistant subpopulations.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Ninety-seven percent of isolates were shown to be heteroresistant to at least one antibiotic. Heteroresistance to at least two antibiotics was exhibited by 72.1% of strains. The prevalence of heteroresistance varied across antibiotics, with proportions ranging from 1.5% for imipenem to 85.1% for polymyxin B. The case of Kp486 was heteroresistant to amikacin, ceftazidime\/avibactam, tigecycline and polymyxin B. The resistant subpopulations displayed distinct PAP curves and differences in growth and killing kinetics, indicating independent mechanisms for heteroresistance to each of the four antibiotics. Dual PAP experiments showed enhanced killing effects for combinations of antibiotics. In time\u2013kill experiments, pairwise combinations of four drugs achieved a reduction of 3 to 6 logs within 6\u2005h, preventing regrowth of resistant subpopulations. However, combinations with ampicillin did not enhance the activity of tigecycline, polymyxin B or ceftazidime\/avibactam.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Heteroresistance in clinical K. pneumoniae is common and can complicate treatment outcomes. The effects of combination antibiotic therapy depend on the heteroresistance of bacteria to both drugs.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jacamr\/dlaf071","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T09:20:21Z","timestamp":1747128021000},"source":"Crossref","is-referenced-by-count":8,"title":["Overview of heteroresistance to multiple antibiotics in clinical <i>Klebsiella pneumoniae<\/i> isolates and combination therapeutic strategies"],"prefix":"10.1093","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0615-0048","authenticated-orcid":false,"given":"Qiaoyu","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Nosocomial Infection Control, Fujian Medical University Union Hospital , Fuzhou, Fujian 350001 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lirong","family":"Wen","sequence":"additional","affiliation":[{"name":"Department of Nosocomial Infection Control, Fujian Medical University Union Hospital , Fuzhou, Fujian 350001 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Nosocomial Infection Control, Fujian Medical University Union Hospital , Fuzhou, Fujian 350001 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linwen","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Nosocomial Infection Control, Fujian Medical University Union Hospital , Fuzhou, Fujian 350001 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuli","family":"Nie","sequence":"additional","affiliation":[{"name":"Department of Nosocomial Infection Control, Fujian Medical University Union Hospital , Fuzhou, Fujian 350001 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiansen","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Nosocomial Infection Control, Fujian Medical University Union Hospital , Fuzhou, Fujian 350001 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,5,13]]},"reference":[{"key":"2025053006322525900_dlaf071-B1","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1128\/CMR.00058-14","article-title":"Antimicrobial heteroresistance: an emerging field in need of clarity","volume":"28","author":"El-Halfawy","year":"2015","journal-title":"Clin Microbiol Rev"},{"key":"2025053006322525900_dlaf071-B2","doi-asserted-by":"publisher","first-page":"868991","DOI":"10.3389\/fmicb.2022.868991","article-title":"Heteroresistance is associated with in vitro regrowth during colistin treatment in carbapenem-resistant Klebsiella pneumoniae","volume":"13","author":"Wang","year":"2022","journal-title":"Front Microbiol"},{"key":"2025053006322525900_dlaf071-B3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12929-023-00914-6","article-title":"Multiple heteroresistance to tigecycline and colistin in Acinetobacter baumannii isolates and its implications for combined antibiotic treatment","volume":"30","author":"Jo","year":"2023","journal-title":"J Biomed Sci"},{"key":"2025053006322525900_dlaf071-B4","doi-asserted-by":"publisher","first-page":"671153","DOI":"10.3389\/fmicb.2021.671153","article-title":"Characterization of tigecycline-heteroresistant Klebsiella pneumoniae clinical isolates from a Chinese tertiary care teaching hospital","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Microbiol"},{"key":"2025053006322525900_dlaf071-B5","doi-asserted-by":"publisher","first-page":"e02448-17","DOI":"10.1128\/mBio.02448-17","article-title":"Carbapenem-resistant Klebsiella pneumoniae exhibiting clinically undetected colistin heteroresistance leads to treatment failure in a murine model of infection","volume":"9","author":"Band","year":"2018","journal-title":"mBio"},{"key":"2025053006322525900_dlaf071-B6","doi-asserted-by":"publisher","first-page":"449","DOI":"10.3390\/ijms23010449","article-title":"Antibiotic heteroresistance in Klebsiella pneumoniae","volume":"23","author":"Stojowska-Sw\u0119drzy\u0144ska","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2025053006322525900_dlaf071-B7","doi-asserted-by":"publisher","first-page":"e277","DOI":"10.1016\/S1473-3099(23)00426-7","article-title":"Heteroresistance to cefepime-taniborbactam in metallo-\u03b2-lactamase-encoding Enterobacterales","volume":"23","author":"Abbott","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"2025053006322525900_dlaf071-B8","doi-asserted-by":"publisher","first-page":"e0015221","DOI":"10.1128\/Spectrum.00152-21","article-title":"Combined effect of polymyxin B and tigecycline to overcome heteroresistance in carbapenem-resistant Klebsiella pneumoniae","volume":"9","author":"Tian","year":"2021","journal-title":"Microbiol Spectr"},{"key":"2025053006322525900_dlaf071-B9","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/s41579-019-0218-1","article-title":"Mechanisms and clinical relevance of bacterial heteroresistance","volume":"17","author":"Andersson","year":"2019","journal-title":"Nat Rev Microbiol"},{"key":"2025053006322525900_dlaf071-B10","doi-asserted-by":"publisher","first-page":"e3001346","DOI":"10.1371\/journal.pbio.3001346","article-title":"Heteroresistance to beta-lactam antibiotics may often be a stage in the progression to antibiotic resistance","volume":"19","author":"Band","year":"2021","journal-title":"PLoS Biol"},{"key":"2025053006322525900_dlaf071-B11","doi-asserted-by":"publisher","first-page":"103582","DOI":"10.1016\/j.sjbs.2023.103582","article-title":"Conventional methods and future trends in antimicrobial susceptibility testing","volume":"30","author":"Salam","year":"2023","journal-title":"Saudi J Biol Sci"},{"key":"2025053006322525900_dlaf071-B12","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.3389\/fmicb.2019.02029","article-title":"Ceftazidime\/avibactam improves the antibacterial efficacy of polymyxin B against polymyxin B heteroresistant KPC-2-producing Klebsiella pneumoniae and hinders emergence of resistant subpopulation in vitro","volume":"10","author":"Ma","year":"2019","journal-title":"Front Microbiol"},{"key":"2025053006322525900_dlaf071-B13","doi-asserted-by":"publisher","first-page":"16053","DOI":"10.1038\/nmicrobiol.2016.53","article-title":"Antibiotic failure mediated by a resistant subpopulation in Enterobacter cloacae","volume":"1","author":"Band","year":"2016","journal-title":"Nat Microbiol"},{"key":"2025053006322525900_dlaf071-B14","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/s42003-021-02052-x","article-title":"The highly dynamic nature of bacterial heteroresistance impairs its clinical detection","volume":"4","author":"Pereira","year":"2021","journal-title":"Commun Biol"},{"key":"2025053006322525900_dlaf071-B15","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S1473-3099(21)00194-8","article-title":"Widespread cefiderocol heteroresistance in carbapenem-resistant gram-negative pathogens","volume":"21","author":"Choby","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"2025053006322525900_dlaf071-B16","doi-asserted-by":"publisher","first-page":"1332458","DOI":"10.3389\/fmicb.2024.1332458","article-title":"Detection and characterization of eravacycline heteroresistance in clinical bacterial isolates","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Microbiol"},{"key":"2025053006322525900_dlaf071-B17","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/s41579-024-01054-w","article-title":"ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics","volume":"22","author":"Miller","year":"2024","journal-title":"Nat Rev Microbiol"},{"key":"2025053006322525900_dlaf071-B18","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/j.1699-0463.1986.tb03066.x","article-title":"Population analysis of susceptibility to ciprofloxacin and nalidixic acid in Staphylococcus, Pseudomonas aeruginosa, and Enterobacteriaceae","volume":"94","author":"S\u00f8gaard","year":"1986","journal-title":"Acta Pathol Microbiol Immunol Scand B"},{"key":"2025053006322525900_dlaf071-B19","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1038\/s41564-019-0480-z","article-title":"Antibiotic combinations that exploit heteroresistance to multiple drugs effectively control infection","volume":"4","author":"Band","year":"2019","journal-title":"Nat Microbiol"},{"key":"2025053006322525900_dlaf071-B20","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1093\/jac\/dku168","article-title":"Combination therapy for carbapenem-resistant Gram-negative bacteria","volume":"69","author":"Paul","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"2025053006322525900_dlaf071-B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/00365548.2013.844350","article-title":"Epidemiology and outcome of infections with carbapenem-resistant Gram-negative bacteria treated with polymyxin B-based combination therapy","volume":"46","author":"Crusio","year":"2014","journal-title":"Scand J Infect Dis"},{"key":"2025053006322525900_dlaf071-B22","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1080\/22221751.2021.1906163","article-title":"Molecular characterization of carbapenem-resistant and virulent plasmids in Klebsiella pneumoniae from patients with bloodstream infections in China","volume":"10","author":"Yang","year":"2021","journal-title":"Emerg Microbes Infect"},{"key":"2025053006322525900_dlaf071-B23","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1080\/22221751.2019.1601031","article-title":"Detection and characterization of tigecycline heteroresistance in E. cloacae: clinical and microbiological findings","volume":"8","author":"Liu","year":"2019","journal-title":"Emerg Microbes Infect"},{"key":"2025053006322525900_dlaf071-B24","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1128\/CMR.05041-11","article-title":"Combination therapy for treatment of infections with Gram-negative bacteria","volume":"25","author":"Tamma","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"2025053006322525900_dlaf071-B25","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1128\/AAC.01571-06","article-title":"Activity of colistin against heteroresistant Acinetobacter baumannii and emergence of resistance in an in vitro pharmacokinetic\/pharmacodynamic model","volume":"51","author":"Tan","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"2025053006322525900_dlaf071-B26","doi-asserted-by":"publisher","first-page":"3148","DOI":"10.1093\/jac\/dkw293","article-title":"Polymyxin B in combination with doripenem against heteroresistant Acinetobacter baumannii: pharmacodynamics of new dosing strategies","volume":"71","author":"Rao","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"2025053006322525900_dlaf071-B27","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.3390\/jcm8091444","article-title":"Colistin heteroresistance in Klebsiella pneumoniae isolates and diverse mutations of PmrAB and PhoPQ in resistant subpopulations","volume":"8","author":"Cheong","year":"2019","journal-title":"J Clin Med"}],"container-title":["JAC-Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jacamr\/article-pdf\/7\/3\/dlaf071\/63163357\/dlaf071.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jacamr\/article-pdf\/7\/3\/dlaf071\/63163357\/dlaf071.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T10:32:35Z","timestamp":1748601155000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jacamr\/article\/doi\/10.1093\/jacamr\/dlaf071\/8129368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,4,29]]}},"URL":"https:\/\/doi.org\/10.1093\/jacamr\/dlaf071","relation":{},"ISSN":["2632-1823"],"issn-type":[{"value":"2632-1823","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,6]]},"published":{"date-parts":[[2025,4,29]]},"article-number":"dlaf071"}}